The Digital Revolution in Vascular Health
Preventric arms physicians, payers, and patients with actionable and reliable data that combats the root causes of hypertension. This data will help define the future of vascular health.
Preventric expects to create a paradigm shift in measuring and treating hemodynamics. Imagine using the BPro® wearable device to capture clinical data sufficient to confirm a vascular health diagnosis and algorithmically provide access to a custom treatment or solution delivered to the patient’s doorstep. That’s our vision. Preventric already helps identify disease earlier and enables physicians to intervene non-invasively, with greater precision, and often at a lower cost. This dual selling proposition – better information today, advanced analytics tomorrow – creates a powerful investment opportunity.
The Preventric Solution
The Preventric BPro® device measures blood pressure all day and all night, enabling critical insight into when and why hypertension increases. Detailed intuitive reports help isolate the underlying causes of hypertension quickly and accurately, leading to better treatments and outcomes. This FDA cleared system dramatically improves the patient experience for treating hypertension, leading directly to more vital clinical adherence and better patient outcomes.
More importantly, the Preventric system uses digital devices to build a deep and continually growing database on vascular health. This information, coupled with a powerful artificial intelligence engine, will deliver advanced analytics for predictice and prescriptive diagnoses that aren’t possible using other solutions. The powerful combination of digital data collection today and AI-driven analytics tomorrow enables ongoing opportunities for market segment disruption and a substantial barrier to entry for any potential future competition.
A majority of competitors are well funded, larger, and have more significant experience in this market. However, as a fully integrated value chain offering, there is little direct competition. Preventric believes the market’s demands will outpace industry capacity in the foreseeable future.
Learn more about Preventric
Scientifically & Clinically Proven
The Journal of Clinical Hypertension
Comparison of Two Noninvasive Devices for Measurement of Central Systolic Blood Pressure With Invasive Measurement During Cardiac Catheterization [READ MORE]
Journal of the American College of Cardiology
Development and validation of a novel method to derive central aortic systolic pressure from the radial pressure waveform using an n-point moving average method [READ MORE]
Current Hypertension Reviews
Clinical Assessment of Central Blood Pressure [READ MORE]
A Reimbursable Revolution in Vascular Health
Preventric built its solutions to benefit both physicians and payers as well as patients. We’ve worked closely with payers to ensure that our solutions have proper CPT and ICD-10 codes and the necessary workflow to integrate reimbursement requests transparently within your regular business operations.
Learn more about Preventric
What People Say
Russ Ronson, MD
Furthermore, as an additional benefit, the data obtained with BPro® will allow pharmaceutical companies to target their audience and promote their product appropriately. The patients love the device. They feel incorporated into their care, and since they are getting cutting edge treatment.